How CAR T-Cell Therapy Impacts Relapsed/Refractory MM Treatment

Opinion
Video

Yi Lin, MD, PhD, provides insights on the impact of CAR T-cell therapy on the evolving multiple myeloma treatment landscape.

Video content above is prompted by the following questions:

  • What is the impact of CAR T-cell therapy on patient quality of life and how does it compare to other available treatments?
    • How do patients typically respond to CAR T-cell therapy in terms of their overall well-being and ability to perform daily activities?
    • Are there any long-term quality of life benefits or challenges associated with CAR T-cell therapy?
Related Videos
Amrita Y. Krishnan, MD, and Binod Dhakal, MD
Amrita Y. Krishnan, MD, and Binod Dhakal, MD
A panel of 4 experts on multiple myeloma
Video 1 - 4 KOLs are featured in "Triaging and Prioritizing Patients with Multiple Myeloma"
Video 1 - 4 KOLs are featured in "CAR T-Cell Therapy: Leukapheresis Practices"
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Related Content